2017 Ohio Revised Code
Title [47] XLVII OCCUPATIONS - PROFESSIONS
Chapter 4725 - OPTOMETRISTS; DISPENSING OPTICIANS
Section 4725.31 - [Effective Until 1/21/2018] Clinically significant drug-induced side effects.
An optometrist licensed by the state board of optometry shall promptly report to the board any instance of a clinically significant drug-induced side effect in a patient due to the optometrist's administering, employing, applying, or prescribing a topical ocular or therapeutic pharmaceutical agent to or for the patient. The board, by rule adopted in accordance with Chapter 119. of the Revised Code, shall establish reporting procedures and specify the types of side effects to be reported. The information provided to the board shall not include the name of or any identifying information about the patient.
Effective Date: 03-09-1999 .
Note: This section is set out twice. See also § 4725.31, as amended by 132nd General Assembly File No. TBD, HB 49, §130.11, eff. 1/21/2018.
